Latest financial news
Celyad to Present at Cowen and Company 37th Annual Health Care Conference
Information on the total number of voting rights and shares (Articles 15 of the Law of 2 May 2007)
Celyad announces third quarter 2016 business update
May 05, 2017
Annual Shareholders Meeting
May 19, 2017
Q1 2017 - Business Update
August 29, 2017
Half Year Results - H1 2017
November 17, 2017
Q3 2017 - Business Update
Developing breakthrough pioneering therapies for life-threatening diseases.
Celyad is a biopharmaceutical company, specialized in cell therapy, that is developing landmark technologies aimed at treating severe diseases with poor prognosis. Our scientific approach is inspired by the natural mechanisms that are used by the body to fight disease.